THE Therapeutic Goods Administration (TGA) has committed to support a new international recognition framework being introduced by Britain's Medicines and Healthcare products Regulatory Agency (MHRA) in the wake of the UK's exit from the EU.
The new framework will allow MHRA to utilise the work of, and regulatory decisions made by, seven nominated international regulatory counterparts to assist in its sovereign decision making.
MHRA's arrangements will be in place by the first quarter of 2024, with the TGA noting it works closely with other regulators and international networks to "where possible reduce the regulatory burden on sponsors and bring safe and effective products to patients as quickly as possible".
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jun 23
